Abstract
Acquired copper deficiency constitutes an under-recognised cause of myelopathy. Aim of the study was to describe the clinical and imaging features at admission and after copper supplementation of a patient with acquired copper deficiency myeloneuropathy. A 73-year-old woman presented with anaemia and signs of posterior column dysfunction. Somatosensory evoked potentials showed impaired central pathway conduction. Serum copper and caeruloplasmin levels were low. Nerve conduction assessment revealed axonal polyneuropathy. Spinal magnetic resonance imaging (MRI) showed posterior column hyperintensity. Diffusion tensor imaging disclosed decreased fractional anisotropy (FA) corresponding to the hyperintensity. Copper supplementation normalised the haematological picture, whereas vibratory sensitivity was only slightly improved. Control MRI revealed a slight hyperintensity at C1–C2 level; FA values normalised. In conclusion, in acquired copper-deficiency-associated myelopathy, correction of blood and MRI alterations precedes that of neurological manifestations, which may remain suboptimal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Prodan CI, Holland NR, Wisdom PJ, Burstein SA, Bottomley SS (2002) CNS demyelination associated with copper deficiency and hyperzincemia. Neurology 59:1453–1456
Kumar N (2006) Copper deficiency myelopathy (Human swayback). Mayo Clin Proc 81(10):1371–1384
Kumar N, Ahlskog JE, Klein CJ, Port JD (2006) Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology 48(2):78–83
Bottomley SS (2004) Sideroblastic anemias. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds) Wintrobe’s clinical hematology, vol I, 11th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1011–1033
Schleper B, Stuerenburg HJ (2001) Copper deficiency-associated myelopathy in a 46 year old woman. J Neurol 248:705–706
Yaldizli O, Johansson U, Gizewski E, Maschke M (2006) Copper deficiency myelopathy induced by repetitive parenteral supplementation during chronic hemodialysis. J Neurol 253:1507–1509
Goodman BP, Chong BW, Patel AC, Fletcher GP, Smith BE (2006) Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. AJNR 27:2112–2114
Williams DM (1983) Copper deficiency in humans. Semin Hematol 20:118–128
Rowin J, Lewis SL (2005) Copper deficiency myeloneuropathy and pancytopenia secondary to overuse of zinc supplementation. J Neurol Neurosurg Psychiatry 76:750–751
Hedera P, Fink JK, Bockenstedt PL, Brewer GJ (2003) Myelopathy and pancytopenia due to copper deficiency and high zinc levels of unknown origin: further support for existence of a new zinc overload syndrome. Arch Neurol 60:1303–1306
Larner AJ, Zeman AZ, Allen CM, Antoun NM (1997) MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency. J Neurol Neurosurg Psychiatry 62:99–100
Ravina B, Loevner LA, Bank W (2000) MR findings in subacute combined degeneration of the spinal cord: a case of reversible cervical myelopathy. AJR Am J Roentgenol 174:863–865
Hartmann HA, Evenson MA (1992) Deficiency of copper can cause neuronal degeneration. Med Hypotheses 38(1):75–85
Guo AC, MacFall JR, Provenzale JM (2002) Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 222:729–736
Kumar N, Elliott MA, Hoyer JD, Harper CM Jr, Ahlskog JE, Phyliky RL (2005) Myelodysplasia, myeloneuropathy and copper deficiency. Mayo Clin Proc 80(7):943–946
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bolamperti, L., Leone, M.A., Stecco, A. et al. Myeloneuropathy due to copper deficiency: clinical and MRI findings after copper supplementation. Neurol Sci 30, 521–524 (2009). https://doi.org/10.1007/s10072-009-0126-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-009-0126-7